Aeras partners with Crucell to develop TB vaccine

Leiden, The Netherlands, March 24, 2004 Crucell N.V. (Euronext, NASDAQ: CRXL) and the Aeras Global TB Vaccine Foundation of Bethesda, Maryland, announced today a new collaboration on the pre-clinical and clinical development of candidate tuberculosis (TB) vaccines. Aeras has agreed to provide Crucell up to USD$2.9 million contingent upon meeting certain development milestones, for development of TB vaccine candidates.

The Crucell-Aeras TB vaccine program will focus on improvement of the only currently available TB vaccine, Bacillus Calmette-Gurin (BCG), using Crucell's proprietary PER.C6? and AdVac? technologies. With this collaboration contract, Crucell's early stage TB vaccine development is fully funded up to entering the clinic.

"Currently one-third of the world's population is infected with TB, and someone is newly infected every second. A new vaccine is the best hope for defeating this terrible disease," said Dr. Jerald Sadoff, President & Chief Executive Officer of the Aeras Global TB Vaccine Foundation. "We chose Crucell to develop a candidate TB vaccine because the company's vector technology is among the best in the world."

Crucell's tuberculosis and malaria vaccine candidates are both based on the Company's PER.C6™ and AdVac™ technologies. "We see this collaboration with Aeras as a strong endorsement of Crucell's vaccine programs" stated Ronald Brus, Chief Executive Officer of Crucell. "Crucell aims to improve the existing vaccine against TB, a disease which kills over two million people globally per year." Jaap Goudsmit, Chief Scientific Officer at Crucell, added, "Our AdVac™ technology is designed to deliver the protection against TB required at the scale needed to have impact on this devastating TB epidemic. We think we can contribute with our technology to the improvement of global health."

Dr. Sadoff added, "We are very pleased to be working with Crucell and to be able to

Contact: Elizabeth Goodwin
Aeras Global TB Vaccine Foundation

Page: 1 2

Related biology news :

1. Social benefits of wound healing may not make any difference in animals with multiple partners
2. Canadian Society of Agronomy partners with Plant Management Network
3. Unique partnership between UH, FDA opens path for scientific exchange
4. $5 million grant funds partnership, studies of minority-based issues in reproductive health
5. Studies show success of Mectizan partnerships
6. Pioneering discoveries, pursuing new knowledge, fostering partnerships
7. Office Depot partners with Conservation Organizations to incorporate science into paper procurement
8. Childrens Memorial, TGen announce partnership
9. Conservation International & Starbucks expand partnership, launch Verde Ventures loan program
10. $62-million partnership to revolutionize ocean research
11. Carnegie Mellon partners with Pitt to host Bone Symposium

Post Your Comments:

(Date:2/28/2020)... , ... February 26, 2020 ... ... that its patent-pending Rebound PRP™ and Rebound PRF® devices are now available ... new generation of regenerative medical devices, that will provide the most affordable, ...
(Date:2/28/2020)... ... 27, 2020 , ... Regen Suppliers is now offering the top FDA Cleared ... products are not only one of the only FDA Cleared options available, there ... increasing exponentially in popularity, as they represent an excellent nonoperative method of reducing wrinkles ...
(Date:2/28/2020)... ... February 28, 2020 , ... Regen Suppliers is now ... all available stem cell and exosome biologics. , Regen Suppliers offers an extensive ... kits, adipose kits, PDO thread lifts and more. The company is truly ...
Breaking Biology News(10 mins):
(Date:3/19/2020)... ... March 18, 2020 , ... ... bio signals to provide rapid insight into their perceptions of events. Imagine if ... the other. What if they could measure the level of engagement of each ...
(Date:3/12/2020)... ... March 12, 2020 , ... ... microscopy (AFM) technology, increases the business investment in Europe by inaugurating a new ... Grand Opening Ceremony of the new Nanoscience Center Europe took place Tuesday, February ...
(Date:3/10/2020)... ... March 10, 2020 , ... ... to announce the addition of Carson Dickey to its growing engineering team. ... the biopharmaceutical cold chain. He provides design and validation engineering services by ...
(Date:3/4/2020)... ... March 04, 2020 , ... ... recombinant antibody products and services, today announced the launch of its FleXpress™ ... express a large number of antibodies at 80 ml scale. All production ...
Breaking Biology Technology:
Cached News: